We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
101 hedge funds and large institutions have $251M invested in Lexicon Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more call options, than puts
Call options by funds: $169K | Put options by funds: $65K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.29% less ownership
Funds ownership: 81.64% → 80.35% (-1.3%)
8% less funds holding
Funds holding: 110 → 101 (-9)
15% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 39
48% less capital invested
Capital invested by funds: $479M → $251M (-$227M)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
33
Reduced
39
Closed
16
Calls
$169K
Puts
$65K
Net Calls
+$104K
Net Calls Change
+$366K
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$1.16M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.16M |
| 3 |
Walleye Capital
New York
|
+$557K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$551K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$547K |
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
-$3.14M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.05M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$1.02M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$867K |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$788K |
